Journal of Bone and Mineral Research · 2010 · 98 citations · 40 references
MedicineOrthopaedic SurgeryBone AugmentationBone MetabolismMechanobiologyBone FormationBone RemodelingBone ResorptionBone TissueBone TurnoverOsteoclast BiologyExcavationGlucocorticoid Effects On BoneGlucocorticoid-induced Bone LossNew Bone FormationOsteoclast Resorptive CapacityOsteoclast-mediated Bone LossOsteoclast-mediated Bone RemodelingSkeletal Excavation
Osteoclasts are known to exert their resorptive activity through a so-called resorption cycle consisting of alternating resorption and migration episodes and resulting typically in the formation of increasing numbers of discrete round excavations on bone slices. This study shows that glucocorticoids deeply modify this resorptive behavior. First, glucocorticoids gradually induce excavations with a trenchlike morphology while reducing the time-dependent increase in excavation numbers. This indicates that glucocorticoids make osteoclasts elongate the excavations they initiated rather than migrating to a new resorption site, as in control conditions. Second, the round excavations in control conditions contain undegraded demineralized collagen as repeatedly reported earlier, whereas the excavations with a trenchlike morphology generated under glucocorticoid exposure appear devoid of leftovers of demineralized collagen. This indicates that collagenolysis proceeds generally at a lower rate than demineralization under control conditions, whereas collagenolysis rates are increased up to the level of demineralization rates in the presence of glucocorticoids. Taking these observations together leads to a model where glucocorticoid-induced increased collagenolysis allows continued contact of osteoclasts with mineral, thereby maintaining resorption uninterrupted by migration episodes and generating resorption trenches. In contrast, accumulation of demineralized collagen, as prevails in controls, acts as a negative-feedback loop, switching resorptive activity off and promoting migration to a new resorption site, thereby generating an additional resorption pit. We conclude that glucocorticoids change the osteoclastic resorption mode from intermittent to continuous and speculate that this change may contribute to the early bone fragilization of glucocorticoid-treated patients.
40
Robert S. Weinstein, R L Jilka, A. M. Parfitt et al. · Journal of Clinical Investigation · 1998 · 1.8K citations · Full text
Medicine, Endocrinology, Aging +16
Lorenz C. Hofbauer, Francesca Gori, B. Lawrence Riggs et al. · Endocrinology · 1999 · 794 citations · Full text
Glucocorticoids suppress bone formation via the osteoclast
Hyun Ju Kim · Journal of Clinical Investigation · 2006 · 387 citations · Full text